
    
      A multicentre, randomised, double blind, parallel group study to compare the efficacy and
      safety of Salmeterol/Fluticasone propionate combination product (Seretide®) 50/100mcg with
      Fluticasone propionate (Flixotide®) 200mcg, both delivered twice daily via the DISKUS
      inhaler, in the treatment of children aged 6-12 years with symptomatic asthma.
    
  